Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Other Operating Expenses (2010 - 2024)

Grifols' (GIFLF) quarterly Other Operating Expenses came in at -$0.0 in Q4 2024, up 100.0% on a YoY basis from -$0.0 in Q1 2024, and up 100.0% quarter-over-quarter from -$1.9 billion in Q4 2023.

Analysis

Grifols (GIFLF) Other Operating Expenses (2010 - 2024) Analysis & Trends

Grifols (GIFLF) has reported Other Operating Expenses for 14 consecutive years, with -$0.0 the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Other Operating Expenses rose 100.0% year-over-year to -$0.0; the trailing twelve-month figure through Dec 2025 stood at -$1.9 billion (down 287.85% YoY), and the FY2025 full-year result was -$0.0, changed N/A from the prior year.
  • Other Operating Expenses climbed to -$0.0 in Q4 2024 per GIFLF's latest filing, from -$1.9 billion in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.4 billion in Q4 2021 and bottomed at -$1.9 billion in Q4 2023.
  • Historically, Other Operating Expenses has averaged $107.5 million across 4 years, with a median of -$0.0 in 2024.
  • The sharpest annual moves came in 2020 and 2024: Other Operating Expenses dropped 4.15% in 2020, then soared 100.0% in 2024.
  • Over 4 years, Other Operating Expenses stood at $1.4 billion in 2020, then gained by 2.28% to $1.4 billion in 2021, then plunged by 234.74% to -$1.9 billion in 2023, then jumped by 100.0% to -$0.0 in 2024.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered -$0.0, -$1.9 billion, and $1.4 billion for Q4 2024, Q4 2023, and Q4 2021 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 0.00
Dec 31, 2023 -1.90 Bn
Dec 31, 2021 1.41 Bn
Dec 31, 2020 1.38 Bn
Mar 31, 2020 -351.55 Mn
Dec 31, 2019 1.21 Bn
Mar 31, 2019 -337.55 Mn
Jun 30, 2018 1.21 Bn
Mar 31, 2018 -300.11 Mn
Jun 30, 2017 -17.86 Mn
Mar 31, 2017 -308.10 Mn
Sep 30, 2016 0.00
Dec 31, 2015 1.04 Bn
Jun 30, 2015 0.00
Mar 31, 2015 -333.40 Mn
Dec 31, 2014 946.87 Mn
Dec 31, 2013 819.28 Mn
Dec 31, 2012 8.72 Mn
Jun 30, 2012 1.01 Mn
Mar 31, 2012 135,065.50